Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


The circadian clock is disrupted in mice with adenine-induced tubulointerstitial nephropathy.

Motohashi H, Tahara Y, Whittaker DS, Wang HB, Yamaji T, Wakui H, Haraguchi A, Yamazaki M, Miyakawa H, Hama K, Sasaki H, Sakai T, Hirooka R, Takahashi K, Takizawa M, Makino S, Aoyama S, Colwell CS, Shibata S.

Kidney Int. 2020 Apr;97(4):728-740. doi: 10.1016/j.kint.2019.09.032. Epub 2020 Jan 13.


Sleep/Wake Disruption in a Mouse Model of BLOC-1 Deficiency.

Lee FY, Wang HB, Hitchcock ON, Loh DH, Whittaker DS, Kim YS, Aiken A, Kokikian C, Dell'Angelica EC, Colwell CS, Ghiani CA.

Front Neurosci. 2018 Nov 15;12:759. doi: 10.3389/fnins.2018.00759. eCollection 2018.


Circadian-based Treatment Strategy Effective in the BACHD Mouse Model of Huntington's Disease.

Whittaker DS, Loh DH, Wang HB, Tahara Y, Kuljis D, Cutler T, Ghiani CA, Shibata S, Block GD, Colwell CS.

J Biol Rhythms. 2018 Oct;33(5):535-554. doi: 10.1177/0748730418790401. Epub 2018 Aug 7.


Time-Restricted Feeding Improves Circadian Dysfunction as well as Motor Symptoms in the Q175 Mouse Model of Huntington's Disease.

Wang HB, Loh DH, Whittaker DS, Cutler T, Howland D, Colwell CS.

eNeuro. 2018 Jan 3;5(1). pii: ENEURO.0431-17.2017. doi: 10.1523/ENEURO.0431-17.2017. eCollection 2018 Jan-Feb.


Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's disease.

Whittaker DS, Wang HB, Loh DH, Cachope R, Colwell CS.

Pharmacol Res Perspect. 2017 Oct;5(5). doi: 10.1002/prp2.344.


Blue light therapy improves circadian dysfunction as well as motor symptoms in two mouse models of Huntington's disease.

Wang HB, Whittaker DS, Truong D, Mulji AK, Ghiani CA, Loh DH, Colwell CS.

Neurobiol Sleep Circadian Rhythms. 2017 Jan 20;2:39-52. doi: 10.1016/j.nbscr.2016.12.002. eCollection 2017 Jan.


Six weeks daily ingestion of whole blueberry powder increases natural killer cell counts and reduces arterial stiffness in sedentary males and females.

McAnulty LS, Collier SR, Landram MJ, Whittaker DS, Isaacs SE, Klemka JM, Cheek SL, Arms JC, McAnulty SR.

Nutr Res. 2014 Jul;34(7):577-84. doi: 10.1016/j.nutres.2014.07.002. Epub 2014 Jul 8.


Energy transport in short-pulse-laser-heated targets measured using extreme ultraviolet laser backlighting.

Wilson LA, Tallents GJ, Pasley J, Whittaker DS, Rose SJ, Guilbaud O, Cassou K, Kazamias S, Daboussi S, Pittman M, Delmas O, Demailly J, Neveu O, Ros D.

Phys Rev E Stat Nonlin Soft Matter Phys. 2012 Aug;86(2 Pt 2):026406. Epub 2012 Aug 28.


Extreme ultraviolet interferometry of warm dense matter in laser plasmas.

Gartside LM, Tallents GJ, Rossall AK, Wagenaars E, Whittaker DS, Kozlov√° M, Nejdl J, Sawicka M, Polan J, Kalal M, Rus B.

Opt Lett. 2010 Nov 15;35(22):3820-2. doi: 10.1364/OL.35.003820.


Laser-ablation rates measured using x-ray laser transmission.

Edwards MH, Whittaker DS, Tallents GJ, Mistry P, Pert GJ, Rus B, Mocek T, Kozlov√° M, Polan J, Praeg A, Stupka M, Homer P.

Phys Rev Lett. 2007 Nov 9;99(19):195002. Epub 2007 Nov 9.


Determining the accuracy of a rapid point-of-care test for determining Rh(D) phenotype.

Herold TJ, Whittaker DS, Glynn T.

Acad Emerg Med. 2005 May;12(5):474-6.


Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset.

Litherland SA, She JX, Schatz D, Fuller K, Hutson AD, Peng RH, Li Y, Grebe KM, Whittaker DS, Bahjat K, Hopkins D, Fang Q, Spies PD, North K, Wasserfall C, Cook R, Dennis MA, Crockett S, Sleasman J, Kocher J, Muir A, Silverstein J, Atkinson M, Clare-Salzler MJ.

Pediatr Diabetes. 2003 Mar;4(1):10-8.


Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus.

Litherland SA, Xie XT, Hutson AD, Wasserfall C, Whittaker DS, She JX, Hofig A, Dennis MA, Fuller K, Cook R, Schatz D, Moldawer LL, Clare-Salzler MJ.

J Clin Invest. 1999 Aug;104(4):515-23.

Supplemental Content

Loading ...
Support Center